Deka Bank Deutsche Girozentrale Eagle Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$45.82 - $56.9 $316,158 - $392,610	-6,900 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$37.02 - $51.28 $255,438 - $353,832	6,900 New	6,900 $286,000
Q4 2019 Feb 04, 2020	SELL	$54.32 - $64.31 $374,808 - $443,739	-6,900 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $367,425 - $413,862	-6,900 Reduced 50.0%	6,900 $389,000
Q2 2019 Aug 01, 2019	BUY	$46.61 - $58.45 $247,033 - $309,785	5,300 Added 62.35%	13,800 $759,000
Q1 2019 May 10, 2019	BUY	$38.66 - $51.82 $61,855 - $82,912	1,600 Added 23.19%	8,500 $581,000
Q4 2018 Feb 12, 2019	SELL	$36.72 - $67.73 $58,752 - $108,368	-1,600 Reduced 18.82%	6,900 $268,000
Q3 2018 Nov 09, 2018	SELL	$66.65 - $83.86 $13,330 - $16,772	-200 Reduced 2.3%	8,500 $0
Q1 2018 May 03, 2018	SELL	$52.16 - $66.86 $10,432 - $13,372	-200 Reduced 2.25%	8,700 $454,000
Q3 2017 Nov 06, 2017	BUY	$46.62 - $60.36 $414,918 - $537,204	8,900	8,900 $496,000

8.35M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $11.7M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.